CBN and Sleep
One weak human trial; marketing vastly overstates the evidence base.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
CBN became a sleep supplement based on 1970s research that actually showed it *didn't* sedate people on its own. The marketing industry has spent years selling this backwards. One recent trial found 20 mg of CBN modestly reduced subjective sleep disturbance, but that's the entire human evidence base. Most commercial products dose far lower and mix in THC or melatonin anyway. If CBN helps you sleep, melatonin or placebo is just as likely the reason.
Not Medical Advice
This article is not medical advice. It summarizes published research and labels each claim by evidence quality. Sleep problems can be symptoms of underlying conditions (sleep apnea, depression, thyroid disease, medication interactions) that require real diagnosis. If you have chronic insomnia, talk to a clinician before self-treating with any cannabinoid product. Drug interactions with CBN are poorly studied — assume caution if you take other sedatives, benzodiazepines, opioids, or medications metabolized by CYP450 enzymes.
Plain-Language Summary
CBN (cannabinol) is what THC slowly becomes when cannabis is exposed to oxygen, heat, and light over time. Old, poorly stored cannabis contains more CBN than fresh material. In the 1970s, researchers noticed that aged cannabis seemed more sedating and initially attributed the effect to CBN. Later work showed the sedation was likely caused by other degradation products and residual THC, not CBN itself [1][2] Disputed.
Despite this weak origin story, CBN became the centerpiece of a consumer sleep-supplement industry. The current picture: there is one small, placebo-controlled human trial showing CBN modestly reduced subjective sleep disturbance, and a handful of preclinical studies. The evidence is real but weak, and commercial marketing has far outpaced what the science supports.
What Probably Works
Honestly: nothing about CBN for sleep sits at the 'probably works' tier yet. No claim about CBN as a sleep aid has the replicated, adequately powered human trial data needed to reach well-established status No data.
For comparison, treatments that do meet this standard for insomnia include cognitive behavioral therapy for insomnia (CBT-I) and certain prescription medications [3][6]. CBN is not in that category, and any product label implying otherwise is overselling.
What Might Work
Subjective sleep disturbance reduction at 20 mg nightly. A 2024 randomized, double-blind, placebo-controlled trial by Bonn-Miller and colleagues gave healthy adults with mild sleep complaints 20 mg of CBN nightly for one week. The CBN group reported a small but statistically significant reduction on the PROMIS Sleep Disturbance scale compared to placebo, and nighttime awakenings decreased modestly. There was no significant effect on sleep onset latency or total sleep time [4] Weak / limited.
This is the strongest direct human evidence available. However: it is one trial, one week duration, a single dose tested, and conducted in healthy volunteers rather than patients with diagnosed insomnia disorder. The findings are suggestive but not conclusive.
CBN combined with THC. Some users and clinicians report that CBN feels more sedating when paired with low-dose THC. Limited preclinical work suggests additive effects Anecdote, but no controlled human sleep trial has cleanly isolated this combination. Most commercial 'CBN sleep' products also contain THC or melatonin, making it impossible for consumers to determine which ingredient contributes to any observed effect.
What Doesn't Work, or Has Weak Evidence
'CBN is 5 times more sedating than diazepam.' This claim appears frequently in cannabis marketing and is not supported by any published comparative trial in humans. It appears to originate from misapplied or misinterpreted animal data and should be treated as marketing folklore No data.
Low-dose CBN (2.5–5 mg) as a sleep aid. The vast majority of over-the-counter CBN products dose well below the 20 mg used in the only positive human trial. There is no evidence that 2.5 or 5 mg of isolated CBN produces clinically meaningful sleep effects No data. If consumers experience benefit from these products, residual THC, added melatonin, or placebo effect remain plausible explanations.
CBN as a standalone sedative. Early human studies in the 1970s found that pure CBN did not produce sedation in volunteer subjects; only THC + CBN combinations produced drowsiness, and the sedative effect tracked with THC dose [1][2] Disputed. The modern narrative linking CBN to sedation appears to rest on a misreading of these early findings.
What We Don't Know
- Whether CBN helps people with diagnosed insomnia disorder (the Bonn-Miller trial enrolled healthy adults with mild complaints, not clinical patients).
- Optimal dose, frequency, timing, and route of administration. Oral, sublingual, and inhaled pharmacokinetics for sleep are not well characterized.
- Long-term safety with nightly use over weeks, months, or years.
- Effects on sleep architecture (REM sleep, deep sleep stages). THC suppresses REM at higher doses [5]; CBN's effects on sleep architecture have not been studied with polysomnography.
- Specific drug interactions, especially with other central nervous system depressants and medications metabolized by CYP450.
- Whether the effects observed in the one positive trial would replicate in a second, larger trial.
Comparison with Standard Treatments
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment for chronic insomnia per the American College of Physicians and the American Academy of Sleep Medicine [3][6]. It has durable effects, requires no pharmacology, and outperforms most sleep medications over the long term. The evidence base for CBT-I far exceeds that for any cannabinoid.
Prescription hypnotics (z-drugs like zolpidem, benzodiazepines, orexin antagonists like suvorexant) have well-characterized efficacy and established side-effect profiles, including risks of dependence, next-day impairment, and complex sleep behaviors.
Melatonin has modest evidence for sleep-onset problems and circadian rhythm disorders, with a favorable safety profile [7]. Many 'CBN sleep' products include melatonin, which likely contributes more to observed effects than CBN alone.
THC has more direct evidence than CBN for short-term subjective sleep improvement, though tolerance develops, REM sleep is suppressed, and discontinuation can rebound-worsen sleep [5] Weak / limited.
Fair ranking for chronic insomnia: CBT-I >> melatonin / prescription hypnotics >> THC >> CBN.
Risks and Considerations
CBN appears reasonably well-tolerated in limited human data. Reported side effects at 20 mg include mild next-morning drowsiness and, rarely, mild gastrointestinal discomfort [4]. Specific risks to consider:
Drug testing. CBN can cross-react with some immunoassay drug screens designed to detect THC, and commercial CBN products frequently contain measurable residual THC Weak / limited. Do not use if you are subject to workplace, athletic, or legal drug testing.
Product quality and mislabeling. The CBN market is largely unregulated. Independent laboratory testing has repeatedly found mislabeled cannabinoid content in hemp-derived products [8]. Buy only from manufacturers providing current third-party certificates of analysis.
Synthetic vs. natural CBN. Most commercial CBN is synthesized from CBD via chemical conversion. Manufacturing byproducts and unknown isomers may be present depending on the production method and purification steps.
Pregnancy, breastfeeding, adolescents. No safety data exists. Avoid.
Interactions with other medications. Avoid combining with alcohol, benzodiazepines, opioids, or other sedatives without consulting a clinician. See Cannabis and Polypharmacy Risks for more detail.
Sources
- Peer-reviewed Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE. Effects of Δ9-tetrahydrocannabinol and cannabinol in man. Pharmacology. 1975;13(6):502–512.
- Peer-reviewed Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology. 2008;153(2):199–215.
- Peer-reviewed Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125–133.
- Peer-reviewed Bonn-Miller MO, Feldner MT, Bynion TM, et al. A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Experimental and Clinical Psychopharmacology. 2024.
- Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Current Psychiatry Reports. 2017;19(4):23.
- Peer-reviewed Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255–262.
- Peer-reviewed Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews. 2017;34:10–22.
- Peer-reviewed Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318(17):1708–1709.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis and REM Sleep — THC reduces REM sleep reliably; stopping causes vivid rebound dreams. Evidence for other u...
- Cannabis and Sleep Architecture — How cannabinoids alter sleep stages, what works short-term, why tolerance develops, and sa...
- Cannabis Tolerance and Sleep Effects — Short-term sedation, tolerance, rebound insomnia, and why long-term use often backfires.
- Cannabis Withdrawal and Sleep Disruption — Sleep disruption is a hallmark of cannabis withdrawal syndrome and typically resolves with...
- CBD and Sleep — CBD may help anxiety-driven sleep loss, but the science for general insomnia is weak.